Aclarion EBITDA Margin 2021-2025 | ACON
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Aclarion (ACON) over the last 10 years. The current EBITDA margin for Aclarion as of June 30, 2025 is .
| Aclarion EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.00B | $-0.01B | 0.00% |
| 2025-03-31 | $0.00B | $-0.01B | 0.00% |
| 2024-12-31 | $0.00B | $-0.01B | 0.00% |
| 2024-09-30 | $0.00B | $0.00B | 0.00% |
| 2024-06-30 | $0.00B | $0.00B | 0.00% |
| 2024-03-31 | $0.00B | $0.00B | 0.00% |
| 2023-12-31 | $0.00B | $0.00B | 0.00% |
| 2023-09-30 | $0.00B | $0.00B | 0.00% |
| 2023-06-30 | $0.00B | $-0.01B | 0.00% |
| 2023-03-31 | $0.00B | $-0.01B | 0.00% |
| 2022-12-31 | $0.00B | $-0.01B | 0.00% |
| 2022-09-30 | $0.00B | $-0.01B | 0.00% |
| 2022-06-30 | $0.00B | $-0.01B | 0.00% |
| 2022-03-31 | $0.00B | $0.00B | 0.00% |
| 2021-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.004B | $0.000B |
| Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.291B | 27.23 |
| HCA Healthcare (HCA) | United States | $108.760B | 18.01 |
| CVS Health (CVS) | United States | $100.272B | 11.53 |
| Elevance Health (ELV) | United States | $70.623B | 10.36 |
| Cencora (COR) | United States | $69.932B | 22.56 |
| Natera (NTRA) | United States | $27.391B | 0.00 |
| DiDi Global (DIDIY) | China | $25.980B | 21.23 |
| Labcorp Holdings (LH) | United States | $20.950B | 15.97 |
| Medpace Holdings (MEDP) | United States | $16.595B | 41.20 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| ICON (ICLR) | Ireland | $12.852B | 12.75 |
| Solventum (SOLV) | United States | $12.401B | 12.04 |
| CochLear (CHEOY) | Australia | $12.093B | 0.00 |
| Viatris (VTRS) | United States | $11.683B | 4.34 |
| Revvity (RVTY) | United States | $10.292B | 18.95 |
| Charles River Laboratories (CRL) | United States | $8.271B | 15.93 |
| HealthEquity (HQY) | United States | $8.074B | 32.31 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.226B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.746B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.977B | 35.63 |
| Bausch + Lomb (BLCO) | Canada | $5.508B | 36.16 |
| Sotera Health (SHC) | United States | $4.455B | 21.48 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $4.014B | 70.93 |
| Alignment Healthcare (ALHC) | United States | $3.268B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.756B | 34.68 |
| Concentras Parent (CON) | United States | $2.479B | 15.47 |
| Premier (PINC) | United States | $2.324B | 22.52 |
| Progyny (PGNY) | United States | $1.923B | 37.92 |
| Pediatrix Medical (MD) | United States | $1.883B | 11.25 |
| Establishment Labs Holdings (ESTA) | $1.883B | 0.00 | |
| PACS (PACS) | United States | $1.878B | 0.00 |
| Organon (OGN) | United States | $1.763B | 1.92 |
| Teladoc Health (TDOC) | United States | $1.336B | 0.00 |
| Omada Health (OMDA) | $1.169B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.081B | 17.28 |
| Embecta (EMBC) | United States | $0.807B | 4.72 |
| CareDx (CDNA) | United States | $0.803B | 13.13 |
| InnovAge Holding (INNV) | United States | $0.718B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.685B | 9.46 |
| Nutex Health (NUTX) | United States | $0.637B | 9.64 |
| Sonida Senior Living (SNDA) | United States | $0.604B | 0.00 |
| Pomdoctor - (POM) | China | $0.540B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.523B | 0.00 |
| So-Young (SY) | China | $0.449B | 0.00 |
| CryoPort (CYRX) | United States | $0.420B | 0.00 |
| Enhabit (EHAB) | United States | $0.402B | 18.07 |
| Charming Medical (MCTA) | $0.374B | 0.00 | |
| Strata Critical Medical (SRTA) | United States | $0.362B | 0.00 |
| KindlyMD (NAKA) | United States | $0.339B | 0.00 |
| Oncology Institute (TOI) | United States | $0.331B | 0.00 |
| SBC Medicals (SBC) | United States | $0.327B | 7.16 |
| Agilon Health (AGL) | United States | $0.277B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.225B | 0.00 |
| Beauty Health (SKIN) | United States | $0.178B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.124B | 0.00 |
| DocGo (DCGO) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.095B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.89 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |